Subunit Influenza virus Vaccine Antigen

Specification

• Cat#: VAC-0322
• Product Name: Subunit Influenza virus Vaccine Antigen
• Species: Influenza virus
• Formulation: A1/(H1N1)15μg haemagglutinin, A3/(H3N2)15μg haemagglutinin, B/(B)15μg haemagglutinin, excipients including potassium dihydrogen phosphate, sodium hydroxide and water for injection. No thiomersal preservative.
• Storage: Stored and transported at 2-8°C away from light.
• Stability: 12 months
• Usage: Site of inoculation: intramuscular or deep subcutaneous injection.Dose: one dose for children over 3 years of age and adults.Each immune dose was 0.5 mL.
• Product Overview: This product was inoculated in chicken embryo culture with influenza A 1, A 3 and B vaccine strains (northern Hemisphere) recommended by the World Health Organization(WHO), and the subunit vaccine of influenza virus was harvested after the virus venom was inactivated, concentrated, lysed and purified.
• Application: After inoculation of this vaccine, it can stimulate the body to produce immunity against influenza virus, used for the prevention of influenza.
• Adverse Reactions: This product, like all vaccines, may have adverse reactions: 1. Common local adverse reactions are redness, swelling, pain, and sclerosis at the injection site, and systemic reactions may include fever, fatigue, headache, muscle pain, joint pain, etc. Generally after injection 1~2 days soon disappear, does not affect the normal activity. 2. Occasional allergic reaction: usually skin reaction, such as itching, urticaria or specific rash. 3. Rare neuralgia, paresthesias, convulsions, transient thrombocytopenia. 4. Very rare anaphylactic shock, cerebrospinal meningitis, neuritis and Guillain-Barre syndrome. When any adverse reactions not mentioned above occur, the doctor should be notified immediately. The vaccine had no effect on driving and machine operation.
• Package: Prefilling and sealing syringe: 1 syringe per box.
• Appearance: Slightly milky white injected suspension.